Integrated Core Strategies (US) LLC 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-09 4:09 pm Sale |
2025-03-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Integrated Core Strategies (US) LLC | 2,204,044 0.700% |
-14,239,612 (-86.60%) |
Filing |
| 2024-12-10 4:32 pm Purchase |
2024-12-04 | 13G | Pacific Biosciences of California, Inc. PACB |
Integrated Core Strategies (US) LLC | 16,443,656 6.000% |
4,046,919 (+32.65%) |
Filing |
| 2024-11-08 4:16 pm Purchase |
2024-11-04 | 13G | Pacific Biosciences of California, Inc. PACB |
Integrated Core Strategies (US) LLC | 12,396,737 4.500% |
12,396,737 (New Position) |
Filing |